The high expression of AhR in thyroid cancer, as well as its oncogenic function in thyroid cancer, prompted us to investigate whether inhibiting AhR nuclear translocation by AhR antagonists induces differentiation of PTC. This evidence concerns the gene AHR and thyroid gland carcinoma.